Inflammatory Bowel Diseases and Biological Treatment in SARS-CoV-2 Era. Why Not?

Inflamm Bowel Dis. 2020 Jun 18;26(7):e71. doi: 10.1093/ibd/izaa110.
No abstract available

Keywords: COVID-19; SARS-CoV-2; biological treatment; inflammatory bowel diseases.

Publication types

  • Comment

MeSH terms

  • Adult
  • Betacoronavirus
  • COVID-19
  • China
  • Coronavirus Infections
  • Humans
  • Inflammatory Bowel Diseases*
  • Inpatients
  • Pandemics
  • Pneumonia, Viral
  • Retrospective Studies
  • Risk Factors
  • SARS-CoV-2
  • Severe acute respiratory syndrome-related coronavirus*